SCHEMBL68503

SCHEMBL68503

O=C(O)c1ccccc1/N=N/c1ccccc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDE P14735 1/20 0.71
MYC P01106 1/20 0.62
ALDH1A1 P00352 4/20 0.62
ALOX15 P16050 1/20 0.62
MEN1 O00255 6/20 0.61
KMT2A Q03164 6/20 0.61
MAPT P10636 6/20 0.61
NPSR1 Q6W5P4 3/20 0.61
GAA P10253 2/20 0.61
PSMD14 O00487 1/20 0.61
HSP90AA1 P07900 1/20 0.61
MMP2 P08253 1/20 0.61
THRB P10828 1/20 0.61
MAPK1 P28482 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
POLB P06746 3/20 0.57
CCNE2 O96020 1/20 0.57
CCNE1 P24864 1/20 0.57
CDK2 P24941 1/20 0.57
L3MBTL1 Q9Y468 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68504 1.00 IDE (0.71) IDEMYCALDH1A1ALOX15MEN1
Phenol SCHEMBL7057355 0.91 IDE (0.79) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL30884072 0.91 IDE (0.79) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL2481541 0.91 IDE (0.79) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL169230 0.91 IDE (0.79) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL28903951 0.91 IDE (0.79) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL28229539 0.89 IDE (0.77) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL3418834 0.89 IDE (0.66) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL28229538 0.89 IDE (0.77) IDEMYCALDH1A1ALOX15MEN1
SCHEMBL1287836 0.89 IDE (0.66) IDEMYCALDH1A1ALOX15MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112604675-B Preparation method and application of azobenzene dicarboxamide bridged beta-cyclodextrin chiral stationary phase 南昌大学 2022-06-14 CN claimed
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES UNIVERSITÉ DE VERSAILLES - SAINT-QUENTIN-EN-YVELINES (FR) 2021-09-09 US claimed
US-11114691-B2 Sulfide-based solid electrolyte for lithium battery, method of preparing the same, and lithium battery including the sulfide-based solid electrolyte SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-09-07 US claimed
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2021-06-15 US claimed
CN-109294560-B Supramolecular azobenzene-2, 2' -aluminum diformate metal gel luminescent material and preparation method thereof 洛阳师范学院 2021-04-27 CN claimed
CN-112604675-A Preparation method and application of azobenzene dicarboxamide bridged beta-cyclodextrin chiral stationary phase 南昌大学 2021-04-06 CN claimed
EP-3357929-B1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES CENTRE NAT RECH SCIENT (FR) 2020-06-17 EP claimed
US-20200102337-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2020-04-02 US claimed
US-20200052330-A1 SULFIDE-BASED SOLID ELECTROLYTE FOR LITHIUM BATTERY, METHOD OF PREPARING THE SAME, AND LITHIUM BATTERY INCLUDING THE SULFIDE-BASED SOLID ELECTROLYTE SAMSUNG SDI CO., LTD. (KR) 2020-02-13 US claimed
EP-2716360-B9 METHOD FOR PREPARING POROUS ORGANIC-INORGANIC HYBRID MATERIALS KOREA RES INST CHEMICAL TECH (KR) 2019-03-27 EP claimed
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National De La Recherche Scientifique - CNR S (FR) 2011-03-03 US claimed
EP-2260048-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST Centre National de la Recherche Scientifique - CNRS (FR) 2010-12-15 EP claimed
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS- (FR) 2010-09-09 US claimed
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2010-08-19 US claimed
EP-2193136-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE Centre National De La Recherche Scientifique-CNRS (FR) 2010-06-09 EP claimed
EP-2193137-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES Centre National De La Recherche Scientifique-CNRS (FR) 2010-06-09 EP claimed
WO-2010000975-A1 REDUCIBLE POROUS CRYSTALLINE HYBRID SOLID FOR THE SEPARATION OF MIXTURES OF MOLECULES HAVING DIFFERENT DEGREES AND/OR A DIFFERENT NUMBER OF UNSATURATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) 2010-01-07 WO claimed
WO-2009133278-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-11-05 WO claimed
WO-2009077671-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-06-25 WO claimed
WO-2009077670-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) 2009-06-25 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200102337-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES FTO, TPI1, ACP1 IDE 3250/4885MYC 2795/4885ALDH1A1 868/4885
US-20110052650-A1 POROUS CRYSTALLINE HYBRID SOLID FOR ADSORBING AND RELEASING GAS OF BIOLOGICAL INTEREST MITF, SLCO2B1, SLCO2A1 IDE 2031/4885MYC 1382/4885ALDH1A1 2972/4885
US-20100226991-A1 SOLID INORGANIC/ORGANIC HYBRID WITH MODIFIED SURFACE SLCO2A1, SLCO4C1, SLCO2B1 IDE 3420/4885MYC 1974/4885ALDH1A1 150/4885
US-20210277042-A1 LOW TEMPERATURE PROCESS FOR THE SYNTHESIS OF MOF CARBOXYLATE NANOPARTICLES FTO, TPI1, ACP1 IDE 3250/4885MYC 2795/4885ALDH1A1 868/4885
US-20100209354-A1 ORGANIC/INORGANIC HYBRID NANOPARTICULATES MADE FROM IRON CARBOXYLATES SLC39A3, SLC40A1, AOC3 IDE 2880/4885MYC 2860/4885ALDH1A1 488/4885
US-11034711-B2 Low temperature process for the synthesis of MOF carboxylate nanoparticles FTO, TPI1, ACP1 IDE 3250/4885MYC 2795/4885ALDH1A1 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.